Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)e354-e355
JournalJournal of Dermatology
Issue number10
StatePublished - Oct 1 2020

ASJC Scopus subject areas

  • Dermatology

Cite this